Static Chart Cereno Scientific AB

Equities

Delayed Nasdaq Stockholm Other stock markets 10:28:50 2024-06-28 EDT			5-day change	1st Jan Change
4.698 ^SEK	+8.00%		+9.27%	+2.08%

09:28am	First Subject Dosed in Cereno Scientifics First-In-Human Phase I Trial of Novel Hdac Inhibitor Cs014	CI
08:30am	Cereno Scientific AB Announces Phase Ii Trial with Cs1 in Pulmonary Arterial Hypertension Is Closing for Recruitment and Proceeding Topline	CI

Duration

Period